I know you’ve been concerned about Beau. I’m sorry I didn’t get back to you sooner. It’s been a crazy day and I finally have time to sit and let you know what’s going on.
The tests were both in this morning. It’s Dr G’s day off, so he called me from home this afternoon. It was a lot to take in.
BnP is in the normal range at 70, so that’s good. That doesn’t 100% eliminate a heart issue, but it’s a positive.
The cytology was helpful, but not conclusive. No cancer cells, but lots of inflammatory cells. He definitely has a visceral inflammatory response to something. He said his prognosis is still guarded.
He wants to be systematic about the next steps. And he doesn’t want to waste time in case there is something hiding or brewing.
He’s going to start with a new CBC panel tomorrow to see if there are any changes. While it is unlikely, he could have geriatric FIP. But he isn’t “ticking all of the boxes” for markers. His proteins and globulins aren’t elevated. So he’s also going to do an FIP titer. Those results should be in on Monday. He’s still hesitant to drain the ascites yet. The mirtazapine doesn’t seem to be helping much with his appetite, so he’s going to give him a dose of Allur
Dr Wallace, the ultrasound specialist conferred with Dr G again today and said that there were some areas where she couldn’t get a clear look because the fluids were clouding them. So, if the titer comes back negative for FIP, she’ll do the abdominal centesis to drain the fluid and another ultrasound to make sure there’s nothing in those areas she couldn’t see. If he’s positive for FIP, they’ll drain and we’ll discuss treatment options, GS shots or the new Stokes drug.
If he’s negative and the ultrasound shows nothing, he’s concerned that there may be a cardiac situation not on the BnP. So next step would be to do an echocardiogram. The cardiac specialist won’t be in again until the beginning of September and he doesn’t want to wait that long, getting it done sooner than later. We’d end up having to go to another clinic where there is a specialist on site.
So, that’s where we are at this time. No clear answers yet.
